JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141055

Temozolomide, DNA alkylating/methylating chemotherapeutic agent

Be the first to review this product! Submit a review

|

(3 Publications)

MW 194.15 Da, Purity >99%. DNA alkylating/methylating chemotherapeutic agent. Inhibits DNA replication. Anti-cancer and apoptotic activity in vitro and in vivo. Crosses the blood-brain barrier.
1 Images
Chemical Structure - Temozolomide, DNA alkylating/methylating chemotherapeutic agent (AB141055)
  • Chemical Structure

Lab

Chemical Structure - Temozolomide, DNA alkylating/methylating chemotherapeutic agent (AB141055)

2D chemical structure image of ab141055, Temozolomide, DNA alkylating/methylating chemotherapeutic agent

Key facts

CAS number

85622-93-1

Purity

>99%

Form

Solid

form

Molecular weight

194.15 Da

Molecular formula

C<sub>6</sub>H<sub>6</sub>N<sub>6</sub>O<sub>2</sub>

PubChem

5394

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

Biochemical name

Temozolomide

Biological description

DNA alkylating/methylating chemotherapeutic agent. Inhibits DNA replication. Anti-cancer and apoptotic activity in vitro and in vivo. Crosses the blood-brain barrier.

Canonical smiles

CN1C(=O)N2C=NC(=C2N=N1)C(=O)N

InChi

InChI=1S/C6H6N6O2/c1-11-6(14)12-2-8-3(4(7)13)5(12)9-10-11/h2H,1H3,(H2,7,13)

InChiKey

BPEGJWRSRHCHSN-UHFFFAOYSA-N

IUPAC Name

3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
The product can be stored for up to 12 months

Product protocols

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

Oncology letters 29:127 PubMed39807099

2025

Adiponectin facilitates the cell cycle, inhibits cell apoptosis and induces temozolomide resistance in glioblastoma via the Akt/mTOR pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Peng Sun,Fude Liu,Kang Huo,Jianyi Wang,Yawen Cheng,Suhang Shang,Wenlong Ma,Jia Yu,Jianfeng Han

Journal of neurochemistry 168:205-223 PubMed38225203

2024

Molecular prognostic of nine parthanatos death-related genes in glioma, particularly in COL8A1 identification.

Applications

Unspecified application

Species

Unspecified reactive species

Shuangshi Fan,Hao Li,Kun Liu

Bioengineered 13:14125-14137 PubMed35730472

2022

SOCS5 contributes to temozolomide resistance in glioblastoma by regulating Bcl-2-mediated autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Jie Yu,Lin Han,Feng Yang,Mingliang Zhao,Hong Zhou,Linwang Hu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com